Non-Small Cell Lung Cancer Coverage from Every Angle
Advertisement
Advertisement

Leora Horn, MD, on Managing the Adverse Events of Combination Therapies

Posted: Monday, April 15, 2019

Leora Horn, MD, of Vanderbilt University, discusses the challenges of combining tyrosine kinase inhibitors with immunotherapy for lung cancer.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.